Fluticasone Propionate

丙酸氟替卡松

Report date: 2025/11/14 13:58:53
NME

Base Information

Drug NameFluticasone Propionate
Drug Alias Name氟替卡松丙酸酯FlusonalFlunase氟体卡松丙酸酯Flovent Diskus +[29] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCytosolic phospholipase A2 agonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorCytosolic phospholipase A2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)PsoriasisLichen Planus +[31] 
Global Approved IndicationsPsoriasisLichen PlanusPruritus +[16] 
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date1990/12/14
Country/TerritoryBelgiumBulgariaCanada +[34] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLCGlaxosmithkline PlcEms +[7] 
Inactive CompaniesMundipharma Research LtdOffice Of Rare DiseasesResearch Consult Gmbh +[28] 
Active IndicationsPsoriasisLichen PlanusPruritus +[19] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Skin DiseasesDermatitis, Atopic +[12] 

Other Information

ATC CodeD07AC17R01AD08R03BA05
Related LinksWikipediaDrugBankKEGG